Concepedia

Author

Maria Jaswal

Indus HospitalORCID

Also Known As

Jaswal, Maria Rauf, M. Jaswal, M.R. Jaswal, Maria Jaswal, Maria R Jaswal, Maria R. Jaswal, Mrigaank Jaswal

21

Publications

316

Citations

11

H-Index

9

Concepts

All Affiliations

Indus HospitalHarvard UniversityHarvard Global Health InstituteInteractive Research and DevelopmentBrigham and Women's Hospital
MJ

About

Maria Jaswal is an author at Indus Hospital specializing in tuberculosis, tuberculosis prevention, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

91

2

Tuberculosis

2

2

91

3

Drug Resistance

1

1

29

4

Covid-19

1

1

62

5

Drug Safety

1

1

29

Maria Jaswal

×

11

Publications

286

Citations

11

H-Index

YearCitations

Tuberculosis control and care in the era of COVID-19

Amyn A. Malik, Nauman Safdar, Subhash Chandir,

Health Policy and Planning

2020

62

Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study

Natasha Chida, Zara Ansari, Hamidah Hussain,

PLoS ONE

2015

39

Improving childhood tuberculosis detection and treatment through facility-based screening in rural Pakistan

Amyn A. Malik, Farhana Amanullah, Andrew James Codlin,

The International Journal of Tuberculosis and Lung Disease

2018

35

Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen

Amyn A. Malik, Junaid Fuad, Sara Siddiqui,

Clinical Infectious Diseases

2019

29

Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study

Amyn A. Malik, Saira Farooq, Maria Jaswal,

The Lancet Child & Adolescent Health

2021

29

Age-specific Clinical Presentation and Risk Factors for Extrapulmonary Tuberculosis Disease in Children

Melanie Dubois, Meredith B. Brooks, Amyn A. Malik,

The Pediatric Infectious Disease Journal

2022

25

Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting

Courtney M. Yuen, Arman Majidulla, Maria Jaswal,

Clinical Infectious Diseases

2020

21

Factors associated with month 2 smear non-conversion among Category 1 tuberculosis patients in Karachi, Pakistan

Kimberly A. D'Souza, Syed Mohammad Asad Zaidi, Maria Jaswal,

Journal of Infection and Public Health

2017

13

Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure

Amyn A. Malik, Mercedes C. Becerra, Timothy L. Lash,

Clinical Infectious Diseases

2020

11

Predictors of unsuccessful tuberculosis treatment outcomes in children from a prospective cohort study in Pakistan

Meredith B. Brooks, Amyn A. Malik, Salman Khan,

Journal of Global Health

2021

11

Page 1